Lesson plan

Tofersen

Tofersen, sold under the brand name Qalsody, is a medication used for the treatment of amyotrophic lateral sclerosis (ALS). Tofersen is an antisense oligonucleotide that targets the production of superoxide dismutase 1, an enzyme whose mutant form is commonly associated with ALS. It is administered as an intrathecal injection. Tofersen is approved for medical use in the US and EU. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. Common side effects include fatigue, arthralgia, increased cerebrospinal (brain and spinal cord) fluid white blood cells, and myalgia.

Back to article

Article summary

Tofersen, sold under the brand name Qalsody, is a medication used for the treatment of amyotrophic lateral sclerosis (ALS). Tofersen is an antisense oligonucleotide that targets the production of superoxide dismutase 1, an enzyme whose mutant form is commonly associated with ALS. It is administered as an intrathecal injection. Tofersen is approved for medical use in the US and EU. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. Common side effects include fatigue, arthralgia, increased cerebrospinal (brain and spinal cord) fluid white blood cells, and myalgia.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.